Monarcher: A randomized phase 2 study of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with HR+, HER2+advanced breast cancer
Ettl, J Tolaney, S Zambelli, S Hilton, JF Ricci, F Im, SA Kim, SB Johnston, S Chan, A
Ettl, J
Tolaney, S
Zambelli, S
Hilton, JF
Ricci, F
Im, SA
Kim, SB
Johnston, S
Chan, A
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2020
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Faivre-Finn C. Less is more in radiotherapy target volume planning: lessons from the PET-plan trial. Lancet Oncol. 2020;21:481-3.